Danish breast cancer group

Author: vrdz

August undefined, 2024

WebPURPOSE Given the poor results using hypofractionated radiotherapy for early breast cancer, a dose of 50 Gy in 25 fractions (fr) has been the standard regimen used by the Danish Breast Cancer Group (DBCG) since 1982. Results from more recent trials have stimulated a renewed interest in hypofractionation, and the noninferiority DBCG HYPO … WebApr 8, 2024 · In the Danish Breast Cancer Group Internal Mammary Node study, using a unique pragmatic study design, allocation to IMNI was based on cancer laterality: …

Delineation of target volumes and organs at risk in adjuvant

WebDec 5, 2024 · Abstract. Background: Over the past 40 years the Danish Breast Cancer Cooperative Group (DBCG) has made significant contributions to improve outcome and to make treatment of patients with early breast cancer more tolerable through nationwide and international trials evaluating loco-regional and systemic treatments. These trials have … WebMay 15, 1999 · To avoid unwanted side-effects, the trial was regularly monitored by the data centre and the Danish Breast Cancer Cooperative Group steering committee, and … css linking in html

Volume matters: Breast induration is associated with irradiated breast …

WebJan 3, 2024 · In all, 1425 women with ID (25%) were fully screened according to guidelines for the Danish breast cancer screening program compared with 30 480 women in the reference group (62%). Women with ID had nearly 5 times higher odds of never being screened compared with the reference group (odds ratio, 4.90 [95% CI, 4.60-5.22]). WebDanish Breast Cancer Cooperative Group Peer Christiansen,1 Bent Ejlertsen,2,3 Maj-Britt Jensen,3 Henning Mouridsen3 1Department of Surgery P, Breast Surgery Unit, Aarhus University Hospital/Randers Regional Hospital, Aarhus C, 2Department of Oncology, Rigshospitalet, Copenhagen University Hospital, 3DBCG-secretariat, Department 2501, … WebDanish Breast Cancer Cooperative Group. Christiansen P, Ejlertsen B, Jensen MB, Mouridsen H. Clinical Epidemiology 2016, 8:445-449 Published Date: 25 October 2016. earl oliver

Birgitte Offersen, MD, on Partial vs Whole Breast Irradiation for …

[Article Metrics] Danish Breast Cancer Cooperative Group CLEP

WebOne hundred and thirty-three high-risk breast cancer patients entered the DBCG (Danish Breast Cancer Cooperative Group) tumor marker program between May 1978 and June … WebDec 1, 2024 · The relation between breast induration grade 2–3 at 3 years after radiation therapy and irradiated breast volume was investigated for patients in the Danish Breast Cancer Group (DBCG) Partial Breast Irradiation (PBI) trial. METHODS Treatment plan data was obtained from the Danish radiotherapy plan database. css linking two earl oliver hurst

"WebApr 4, 2024 · Offersen: Since April 2016 all Danish breast cancer patients age 60 and older diagnosed with non-lobular breast cancer, max 20 mm, node-negative, ER+, HER2 … " - Danish breast cancer group

Danish breast cancer group

WebThe Breast. Volume 17, Issue 2, April 2008, Pages 138-147. Original article. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: A study from the Danish Breast Cancer Cooperative Group. Author links open overlay panel Anders Husted Madsen a b, Karen Haugaard c, Jan Soerensen d, ... WebNov 4, 2024 · Briefly, the source population included stage I–III Danish female breast cancer patients, ages 35–69 years, diagnosed between 1985 and 2001, and registered with the Danish Breast Cancer Group (DBCG) . Since 1977, the DBCG has enrolled nearly all Danish breast cancer patients younger than 70 years at diagnosis into its clinical …

Did you know?

WebMultifocality as a prognostic factor in breast cancer patients registered in Danish Breast Cancer Cooperative Group (DBCG) 1996–2001. Author links open overlay panel L.E. Joergensen a, K.A. Gunnarsdottir a, C. Lanng b, S. Moeller a, B.B ... The purpose of this study was to investigate the prognostic influence of multifocality in breast cancer ... WebDec 20, 2024 · Purpose: On the basis of low risk of local recurrence in elderly patients with breast cancer after conservative surgery followed by whole breast irradiation (WBI), the Danish Breast Cancer Group initiated the noninferiority external-beam partial breast irradiation (PBI) trial (ClinicalTrials.gov identifier: NCT00892814).We hypothesized that …

WebDec 1, 2024 · The database of the Danish Breast Cancer Group was used to extract data on all patients who started NACT with SB3 and pertuzumab between September 1, 2024 and August 31, 2024. The primary endpoint was pathological complete response (pCR) rate. WebOne-year survival improved from 91% in 2000–2002 to 95% in 2009–2011, while 5-year survival improved from 72% to a predicted 78%. During the entire study period, comorbidity was a strong predictor of the survival of breast cancer patients. However, we observed improvements over time in 1- and 5-year survival for all comorbidity groups.

WebA recent publication led by physicists and clinical oncologists from the Danish Breast Cancer Group (DBCG) in collaboration with a multidisciplinary group of international experts nicely shows how different radiation techniques used for planning PMRT cases with implant-based IBR can significantly differ in dose distribution, mainly exposure of ... WebThe Danish Breast Cancer Cooperative Group (DBCG) was established as a nation-wide multidisciplinary organization in 1977 on the initiative from the Danish Surgical Society.

WebNov 16, 2024 · November 16, 2024. For the first time, new data show that risk for breast cancer recurrence extends past 30 years. The data come from a Danish study involving 20,315 women who were treated for ...

Web20-12-2024. DBCG RT SDM. DBCG RT SDM forsøget lukker for inklusion 31. december 2024.... Værktøjer - Home [dbcg.dk] Udvalg - Home [dbcg.dk] Kvalitetsdatabasen - Home [dbcg.dk] Danish Breast Cancer Group (DBCG) blev grundlagt i 1976 på initiativ af Dansk … Patientinformation om brystkræft. Patientinformation udarbejdet af … Primær Cancer mamma. Kirurgi. DBCG RT Recon; SENOMAC; Strålebehandling. … Retningslinjer/vejledninger - Home [dbcg.dk] I listen er medtaget arbejder med peer-review, som i forskelligt omfang har … Billeddiagnostik - Home [dbcg.dk] Genetik - Home [dbcg.dk] earl olivier alainWebMay 1, 2024 · Background. Between 1982 and 1990 the Danish Breast Cancer Cooperative Group (DBCG) conducted a randomized trial in high-risk pre- and postmenopausal (<70 years) breast cancer patients comparing mastectomy plus adjuvant systemic therapy alone versus the same treatment plus postoperative irradiation. earl olivierWebDanish Breast Cancer Cooperative Group Peer Christiansen,1 Bent Ejlertsen,2,3 Maj-Britt Jensen,3 Henning Mouridsen3 1Department of Surgery P, Breast Surgery Unit, Aarhus University Hospital/Randers Regional Hospital, Aarhus C, 2Department of Oncology, Rigshospitalet, Copenhagen University Hospital, 3DBCG-secretariat, Department 2501, … css link media attributeWebFeb 23, 2024 · From the Danish Breast Cancer Group and other nationwide databases, the study team identified women with early or late breast cancer recurrence during a period from 2004 to 2024, who were alive 6 months after recurrence. They followed these women until breast cancer death, death from other causes, emigration, 10 years, or 31 … earl old person quotesWebNov 1, 2024 · Purpose: Given the poor results using hypofractionated radiotherapy for early breast cancer, a dose of 50 Gy in 25 fractions (fr) has been the standard regimen used by the Danish Breast Cancer Group (DBCG) since 1982. Results from more recent trials have stimulated a renewed interest in hypofractionation, and the noninferiority DBCG HYPO … css link on hoverWebAug 5, 2024 · On the basis of low risk of local recurrence in elderly patients with breast cancer after conservative surgery followed by whole breast irradiation (WBI), the Danish … css link onclickWebNov 2, 2024 · The 15-year results of the European Organisation for Research and Treatment of Cancer (EORTC) 22922/10925 trial, 1 along with the MA.20 ( NCT00005957 ) and Danish Breast Cancer Group (DBCG) trials, 2 suggest that, with the improved efficacy of systemic therapy and if used for patients who are at high risk of internal mammary … earl omer